ISOPP Immunotherapy Survey

Immunotherapy is an important emerging therapy in the treatment of malignant disease. ISOPP recognises and supports the contributions of pharmacy staff across international healthcare systems in providing safe and effective care to patients receiving treatment with immunotherapy agents.

ISOPP has established the Immunotherapy Task Force who are working to develop a White Paper on the role of oncology pharmacy staff in immunotherapy to identify current and ongoing educational and developmental needs of pharmacy professionals.

To this end, the ISOPP Immunotherapy Task Force has commissioned a survey to establish current practices across the globe and help identify and respond to the needs of the profession. This survey is anonymous, and responses will be collated and summarized into a final publication which will detail the steps ISOPP will take to support the pharmacy staff.

Please complete this survey by Thursday, May 6, 2021 via the link below. It will take 10-15 minutes and results will help us to identify areas where the profession feels additional support is required and allow us to champion the role of pharmacy staff in the field of immunotherapy.

Access the Survey HERE: https://www.surveymonkey.com/r/WQ6GGR5

Latest News

By UK SACT Protocols Pilot Team on 20th November 2026

Have Your Say: Review the First UK SACT Protocol and Provide Feedback

Dear Colleagues working in cancer services We are writing to invite you to review and provide feedback on the first protocol produced as part of the UK SACT Protocols Pilot.…

Read article
By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article